Generalized pustular psoriasis (GPP) is considered a rare and severe form of psoriasis that may be treated with a combination of oral medications, topical treatments, and more. Generalized ...

Generalized pustular psoriasis (GPP) can range in severity and may be life threatening for some people. Treatment typically includes a variety of topical, oral, and injectable medications.

Generalized Pustular Psoriasis Market Outlook 2025-2035: The 7 major generalized pustular psoriasis market reached a value of USD 19.6 Billion in 2024. Looking forward, IMARC Group expects the 7MM to ...

The rapid onset and resolution of the pustular eruption upon discontinuation of isotretinoin further supported the diagnosis of AGEP. Isotretinoin has the potential to trigger acute generalized ...

Reason for decision Anticipate the topic will be of importance to patients, carers, professionals, commissioners and the health of the public to ensure clinical benefit is realised, inequalities in ...

"Vanda and AnaptysBio link for generalised pustular psoriasis therapy" was originally created and published by Pharmaceutical Technology, a GlobalData owned brand. The information on this site has ...

More than 125 million people worldwide suffer from some form of psoriasis. If you’ve struggled with your skin health this ...

Credit: Kmpzzz/Shutterstock. Vanda Pharmaceuticals and AnaptysBio have announced an exclusive worldwide licence agreement to develop and commercialise the fully humanised immunoglobulin G4 (IgG4) ...

You should read both the consultation document and the accompanying evidence (see the committee papers) before making any comments. You must make your comments ...

Associations between therapies and quality of life (QoL) in patients with generalized pustular psoriasis (GPP) can differ substantially.